Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Source link
Neurocrine to Buy Soleno for $2.9 Billion
Date:
More like thisRelated
Netanyahu's party lags in polls ahead of first election since Oct. 7, 2023
Benjamin Netanyahu's Likud party is lagging behind in the...
Smith-Njigba has banner day, Seahawks’ defense stifles Chiefs
Nate Taylor and Brady HendersonCloseBrady HendersonESPNBrady Henderson is a reporter for...
SS United States Soon to Become World’s Largest Artificial Reef
DESTIN, Fla. —A historic ocean liner is a step...